Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
236 studies found for:    Open Studies | "Drug Interactions"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Unknown  Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software
Condition: Drug Interactions
Intervention: Other: on line software to detect DI early on
2 Not yet recruiting Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus
Conditions: Drug Interactions;   Kidney Transplantation
Interventions: Drug: Voriconazole;   Drug: Rifampin
3 Recruiting Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
Conditions: Placebo Effect;   Placebo Drug Interaction
Interventions: Drug: Hydroxizine;   Other: Placebo;   Drug: hydroxyzine/placebo
4 Recruiting Interaction of Sevoflurane Propofol and Remifentanil in Anesthesia for Laparoscopic Surgery
Conditions: Drug Interactions;   Anesthesia, Conduction
Interventions: Drug: Propofol and Remifentanil;   Drug: Sevoflurane and Remifentanil;   Drug: SPR 1;   Drug: SPR2
5 Unknown  Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Conditions: PHENYTOIN/SORAFENIB [VA Drug Interaction];   Liver Neoplasms;   Carcinoma, Hepatocellular;   Digestive System Neoplasms;   Neoplasms by Site;   Liver Diseases;   Adenocarcinoma;   Carcinoma;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction];   HBV
Interventions: Procedure: Transarterial Chemoembolization (TACE);   Other: Sorafenib in combination with TACE
6 Recruiting Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients
Condition: Drug Interaction Potentiation
Interventions: Drug: Everolimus;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Drug: Methylprednisolone;   Drug: Prednisolone
7 Unknown  Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz
Condition: Drug Interaction
Intervention: Drug: Efavirenz
8 Recruiting A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential
Condition: Drug Interactions
Interventions: Drug: GSK525762 Besylate Tablets;   Drug: Itraconazole 200 mg;   Drug: Rifampicin 300 mg
9 Recruiting The Drug-drug Interaction of SHR3824 and SP2086
Condition: Type 2 Diabetes
Intervention: Drug: SHR3824, SP2086
10 Unknown  An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions
Condition: Healthy
11 Not yet recruiting A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate
Condition: Drug-Drug Interaction
Interventions: Drug: Raxone (idebenone 150 mg);   Drug: Midazolam 2,5 mg
12 Recruiting Hop Botanical Dietary Supplements - Metabolism and Safety in Women
Condition: Food-Drug Interactions
Intervention: Dietary Supplement: Humulus lupulus
13 Recruiting Pharmacokinetic Drug-Drug Interaction Study of Rucaparib
Condition: Neoplasms
Interventions: Drug: Caffeine;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Midazolam;   Drug: digoxin;   Drug: Vitamin K;   Drug: Rucaparib
14 Recruiting Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients
Condition: HIV-1 Infection
Interventions: Drug: darunavir/cobicistat;   Drug: etravirine
15 Recruiting Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects
Condition: Healthy Participants
Interventions: Drug: Avatrombopag;   Drug: Fluconazole;   Drug: Itraconazole;   Drug: Rifampin
16 Unknown  TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma
Conditions: PHENYTOIN/SORAFENIB [VA Drug Interaction];   Carcinoma, Hepatocellular
Interventions: Procedure: TACE;   Drug: sorafenib combined with TACE
17 Recruiting Counseling on the Interaction of Hormonal Contraceptives and Antiepileptics
Condition: Epilepsy
Intervention: Other: Educational handout
18 Recruiting Drug Interaction With Genes in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Other: Identification of genes
19 Recruiting Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
Conditions: Cytochrome P450 CYP2D6 Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   CYP2D6 Polymorphism
Interventions: Genetic: Pharmacogenetic testing;   Other: Software-based drug & gene interaction risk analysis;   Other: MTM
20 Unknown  Herb Drug Interaction of Traditional Chinese Herb and Commonly Used Drugs
Condition: Healthy
Interventions: Drug: Nalbuphine;   Drug: Morphine;   Drug: Morphine with Long dan xie gan tang;   Drug: Nalbuphine with Long dan xie gan tang;   Drug: Nubian with Long dan xie gan tang

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years